N. Witte

Insider Reports History

Entity
Individual
Location
C/O Allogene Therapeutics, Inc., 210 East Grand Avenue, South San Francisco, CA
Signature
/s/Owen Witte
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by N. Witte:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. Director Common Stock 293K $930K $3.17 Jun 13, 2023 Direct
Allogene Therapeutics, Inc. Director Stock Option (Right to buy) 191K Jun 5, 2024 Direct

Insider Reports Filed by N. Witte

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALLO Allogene Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
ALLO Allogene Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
ALLO Allogene Therapeutics, Inc. Aug 11, 2022 2 -$251K 4 Aug 15, 2022 Director
ALLO Allogene Therapeutics, Inc. Aug 11, 2022 2 -$251K 4 Aug 15, 2022 Director
ALLO Allogene Therapeutics, Inc. Jun 22, 2022 1 -$118K 4 Jun 23, 2022 Director
ALLO Allogene Therapeutics, Inc. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
ALLO Allogene Therapeutics, Inc. Sep 9, 2021 1 -$128K 4 Sep 9, 2021 Director
ALLO Allogene Therapeutics, Inc. Aug 20, 2021 2 -$235K 4 Aug 23, 2021 Director
ALLO Allogene Therapeutics, Inc. Jun 9, 2021 2 -$250K 4 Jun 11, 2021 Director